Ani Pharmaceuticals (ANIP) Exchange Rate Effect (2024 - 2026)
Ani Pharmaceuticals' (ANIP) quarterly Exchange Rate Effect came in at $156000.0 in Q1 2026, up 152.53% year-on-year from $61776.0 in Q1 2025, and up 111.53% quarter-over-quarter from -$1.4 million in Q4 2025.
Ani Pharmaceuticals (ANIP) Exchange Rate Effect (2024 - 2026) Analysis & Trends
Ani Pharmaceuticals has disclosed Exchange Rate Effect across 3 years of filings, most recently posting $156000.0 for Q1 2026.
- Exchange Rate Effect for Q1 2026 came in at $156000.0, up 152.53% year-over-year; the trailing twelve-month figure through Mar 2026 was $220000.0 (up 128.68% YoY), and the FY2025 annual result was -$233000.0, up 50.43% from the prior year.
- Exchange Rate Effect came in at $156000.0 for Q1 2026 at Ani Pharmaceuticals, up from -$1.4 million in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $841000.0 in Q2 2025 to a low of -$1.4 million in Q4 2025.
- The 3-year median for Exchange Rate Effect is -$75000.0 (2024), against an average of -$78142.9.
- Peak annual rise in Exchange Rate Effect reached 868.0% in 2025, while the deepest fall reached 242.53% in 2025.
- Ani Pharmaceuticals' Exchange Rate Effect stood at -$395000.0 in 2024, then plunged by 242.53% to -$1.4 million in 2025, then surged by 111.53% to $156000.0 in 2026.
- The last three Exchange Rate Effect figures came in at $156000.0 (Q1 2026), -$1.4 million (Q4 2025), and $576000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FX Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | -17.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 17.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | -5.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | -22,000.00 |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -2.38 Mn |
| 10 | Ani Pharmaceuticals | 1.68 Bn | 1.37 Bn | 143.88 Mn | 156,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 156,000.00 |
| Mar 31, 2026 | 156,000.00 |
| Dec 31, 2025 | -1.35 Mn |
| Dec 31, 2025 | -1.35 Mn |
| Sep 30, 2025 | 576,000.00 |
| Sep 30, 2025 | 576,000.00 |
| Jun 30, 2025 | 841,000.00 |
| Jun 30, 2025 | 841,000.00 |
| Mar 31, 2025 | -297,000.00 |
| Mar 31, 2025 | -297,000.00 |
| Dec 31, 2024 | -395,000.00 |
| Dec 31, 2024 | -395,000.00 |
| Sep 30, 2024 | -75,000.00 |
| Sep 30, 2024 | -75,000.00 |